Treatment Registry
TR-0798 ActiveRecorded September 2026

Unspecified GLP-1

Sold by Gatlan · every unspecified glp-1 record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

Recorded initial charges

First month

$125

first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.

Medication · Medical Weight Loss, starting price · recorded initial monthly payment$125

Added from the figures recorded below.

Price

TermPer monthCharged today
Medical Weight Loss, starting price

“Medical Weight Loss METABOLIC HEALTH Advanced incretin mimetics for sustainable weight management. From $125/mo GET STARTED”

Per month$125Charged today$125
Price sources
Visit Gatlan

We earn nothing from this link. It opens Gatlan's website without a paid referral.

History

Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.

  • September 2026 — Entry added to the register

Sourcing and terms

PrescriberAsynchronous review
CancellationWhile refunds are generally not provided for the Services, Gatlan acknowledges that there may be exceptional circumstances warranting a partial or full refund. In such cases, Gatlan will carefully review the circumstances and, at its sole and absolute discretion, determine whether a refund of any kind is appropriate.

Not yet checked: pharmacy, states, membership and consult fee.

Recorded from gatlan.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2026 — /pricing, /weight-loss, and /semaglutide all redirect to the homepage; real content is at /mens-health-products/, /womens-health-products/, and /health-optimization-products/ (identical content on all three). Neither semaglutide nor tirzepatide is named anywhere — the site only says 'GLP-1 and GLP-1/GIP medications' and 'advanced incretin mimetics', and explicitly states 'Gatlan does not offer Retatrutide or any unapproved triple-receptor agonist treatments. Our weight management programs strictly utilize FDA-approved single and dual-agonist therapies' — this phrase suggests brand medication but no brand name (Wegovy/Ozempic/Zepbound/Mounjaro) is ever printed, so drug is recorded as unspecified GLP-1 rather than assumed. No page stating served states was found (checked homepage, all three product pages, and terms). No cancellation-specific page exists; the only relevant text is a discretionary, non-guaranteed refund clause in the Terms of Service.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0798
Medication category
unspecified GLP-1
Readings
1

Related records

Unspecified GLP-1 at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 73 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Gatlan — unspecified GLP-1 (TR-0798). Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0798

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.